CONTEXT: The obese insulin-resistant state is characterized by elevated lipid storage in skeletal muscle tissue. OBJECTIVE: We tested whether differences in muscle triacylglycerol (TAG) and diacylglycerol (DAG) lipase content and activity are associated with incomplete in vivo lipolysis and lipid accumulation. DESIGN AND PATIENTS: Two case-control studies were conducted on skeletal muscle biopsies from lean (n=13) and obese (n=10) men (study 1) and from 11 nonobese type 2 diabetic (T2D), obese T2D, and healthy normoglycemic men (study 2). MAIN OUTCOME MEASURES: Skeletal muscle lipase protein content and activity and muscle lipid content (TAG and DAG) were determined. RESULTS: Skeletal muscle hormone-sensitive lipase protein content was lower (0.39±0.07 vs. 1.00±0.19 arbitrary units; P=0.004) and adipose triglyceride lipase protein content was higher in obese men compared with lean controls (2.17±0.40 vs. 0.42±0.23 arbitrary units; P=0.008). This apparent difference in lipase content was accompanied by a 60% lower ratio of DAG to TAG hydrolase activity in the obese men (11.4±2.3 vs. 26.5±7.3 nmol/h·mg; P=0.045), implying incomplete lipolysis. Lower hormone-sensitive lipase and higher adipose triglyceride lipase content was confined to obesity per se, because it was observed solely in obese T2D men but not in healthy normoglycemic controls and nonobese T2D men. Muscle total DAG content was not higher in obese men but was even lower (6.2±0.7 vs. 9.4±0.9 μmol/mg dry weight; P=0.017). TAG content did not differ between groups (84.7±18.9 vs. 70.4±12.4 μmol/mg dry weight; P=0.543). CONCLUSIONS: Our data do not support an important role of total muscle DAG content in the development of insulin resistance in obese men.
CONTEXT: The obese insulin-resistant state is characterized by elevated lipid storage in skeletal muscle tissue. OBJECTIVE: We tested whether differences in muscle triacylglycerol (TAG) and diacylglycerol (DAG) lipase content and activity are associated with incomplete in vivo lipolysis and lipid accumulation. DESIGN AND PATIENTS: Two case-control studies were conducted on skeletal muscle biopsies from lean (n=13) and obese (n=10) men (study 1) and from 11 nonobese type 2 diabetic (T2D), obese T2D, and healthy normoglycemic men (study 2). MAIN OUTCOME MEASURES: Skeletal muscle lipase protein content and activity and muscle lipid content (TAG and DAG) were determined. RESULTS: Skeletal muscle hormone-sensitive lipase protein content was lower (0.39±0.07 vs. 1.00±0.19 arbitrary units; P=0.004) and adipose triglyceride lipase protein content was higher in obesemen compared with lean controls (2.17±0.40 vs. 0.42±0.23 arbitrary units; P=0.008). This apparent difference in lipase content was accompanied by a 60% lower ratio of DAG to TAG hydrolase activity in the obesemen (11.4±2.3 vs. 26.5±7.3 nmol/h·mg; P=0.045), implying incomplete lipolysis. Lower hormone-sensitive lipase and higher adipose triglyceride lipase content was confined to obesity per se, because it was observed solely in obese T2D men but not in healthy normoglycemic controls and nonobese T2D men. Muscle total DAG content was not higher in obesemen but was even lower (6.2±0.7 vs. 9.4±0.9 μmol/mg dry weight; P=0.017). TAG content did not differ between groups (84.7±18.9 vs. 70.4±12.4 μmol/mg dry weight; P=0.543). CONCLUSIONS: Our data do not support an important role of total muscle DAG content in the development of insulin resistance in obesemen.
Authors: S O Shepherd; M Cocks; P J Meikle; N A Mellett; A M Ranasinghe; T A Barker; A J M Wagenmakers; C S Shaw Journal: Int J Obes (Lond) Date: 2017-07-24 Impact factor: 5.095
Authors: Johan W E Jocken; Gijs H Goossens; Hanneke Boon; Rachael R Mason; Yvonne Essers; Bas Havekes; Matthew J Watt; Luc J van Loon; Ellen E Blaak Journal: Diabetologia Date: 2013-08-02 Impact factor: 10.122
Authors: Boubacar Benziane; Melissa L Borg; Robby Z Tom; Isabelle Riedl; Julie Massart; Marie Björnholm; Marc Gilbert; Alexander V Chibalin; Juleen R Zierath Journal: J Lipid Res Date: 2017-10-24 Impact factor: 5.922
Authors: P M Coen; K C Hames; E M Leachman; J P DeLany; V B Ritov; E V Menshikova; J J Dubé; M Stefanovic-Racic; F G S Toledo; B H Goodpaster Journal: Obesity (Silver Spring) Date: 2013-05-31 Impact factor: 5.002
Authors: Francesca Amati; John J Dubé; Elvis Alvarez-Carnero; Martin M Edreira; Peter Chomentowski; Paul M Coen; Galen E Switzer; Perry E Bickel; Maja Stefanovic-Racic; Frederico G S Toledo; Bret H Goodpaster Journal: Diabetes Date: 2011-08-26 Impact factor: 9.461
Authors: Paul M Coen; Elizabeth V Menshikova; Giovanna Distefano; Donghai Zheng; Charles J Tanner; Robert A Standley; Nicole L Helbling; Gabriel S Dubis; Vladimir B Ritov; Hui Xie; Marisa E Desimone; Steven R Smith; Maja Stefanovic-Racic; Frederico G S Toledo; Joseph A Houmard; Bret H Goodpaster Journal: Diabetes Date: 2015-08-20 Impact factor: 9.461
Authors: William M Steinberg; Michael A Nauck; Bernard Zinman; Gilbert H Daniels; Richard M Bergenstal; Johannes F E Mann; Lasse Steen Ravn; Alan C Moses; Mette Stockner; Florian M M Baeres; Steven P Marso; John B Buse Journal: Pancreas Date: 2014-11 Impact factor: 3.327
Authors: Francesco Schianchi; Jan F C Glatz; Artur Navarro Gascon; Miranda Nabben; Dietbert Neumann; Joost J F P Luiken Journal: Int J Mol Sci Date: 2020-12-11 Impact factor: 5.923